NO920648L - 4-pyrimidonderivater, deres fremstilling og anvendelse - Google Patents
4-pyrimidonderivater, deres fremstilling og anvendelseInfo
- Publication number
- NO920648L NO920648L NO92920648A NO920648A NO920648L NO 920648 L NO920648 L NO 920648L NO 92920648 A NO92920648 A NO 92920648A NO 920648 A NO920648 A NO 920648A NO 920648 L NO920648 L NO 920648L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- optionally substituted
- ring
- branched
- linear
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Liquid Developers In Electrophotography (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Pyrimidinonforbindelser i sine tre tautomere former som svarer til de generelle formler (I), (I1) og (II") (I) (r) R! = rettkjedet eller forgrenet (C1_7)alkyl, rettkjedet eller forgrenet (C3_g) alkenyl eller syklo(C3_7> alkyl (Ci-$) alkyl, R2 = H, rettkjedet eller forgrenet (C1_7)alkyl, syklo(C3_7)- alkyl(C1_3) alkyl, aryl (Cl_-2t alkyl som eventuelt er kjernesubstituert, aryloksy (C!_3) alkyl som eventuelt er aryltio(Ci_3) alkyl som eventuelt er arylsulf onyl (C!_3) alkyl eventuelt heteroaryl (Ci.3) alkyl som eventuelt er kjernesubstituert, kjernesubstituert, kjernesubstituert, kjernesubstituert , R3 = C02H, lH-tetrazol-5-yl, NHCORn, NHS02Ri;l, CONHS02Rn eller CONHOR12, hvori RU = CH3, CF3 eller fenyl som eventuelt er substituert, Ri2 = H, CH3 eller fenyl som eventuelt er substituert, såvel som deres farmasøytisk tålbare organiske eller uorganiske salter. Forbindelsene er nye og har terapeutisk anvendelse, fremstilling er beskrevet.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9102032A FR2672892B1 (fr) | 1991-02-20 | 1991-02-20 | Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique. |
Publications (2)
Publication Number | Publication Date |
---|---|
NO920648D0 NO920648D0 (no) | 1992-02-19 |
NO920648L true NO920648L (no) | 1992-08-21 |
Family
ID=9409925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92920648A NO920648L (no) | 1991-02-20 | 1992-02-19 | 4-pyrimidonderivater, deres fremstilling og anvendelse |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0500409B1 (no) |
JP (1) | JP2529798B2 (no) |
KR (1) | KR920016434A (no) |
CN (1) | CN1034171C (no) |
AT (1) | ATE135695T1 (no) |
AU (1) | AU650319B2 (no) |
CA (1) | CA2061456A1 (no) |
CS (1) | CS49092A3 (no) |
DE (1) | DE69209113T2 (no) |
DK (1) | DK0500409T3 (no) |
ES (1) | ES2086090T3 (no) |
FI (1) | FI920720A (no) |
FR (1) | FR2672892B1 (no) |
GR (1) | GR3019404T3 (no) |
HU (2) | HUT60477A (no) |
IE (1) | IE76145B1 (no) |
IL (1) | IL101014A (no) |
MX (1) | MX9200690A (no) |
NO (1) | NO920648L (no) |
NZ (1) | NZ241659A (no) |
PL (1) | PL168617B1 (no) |
RU (1) | RU2073675C1 (no) |
ZA (1) | ZA921203B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
FR2700543B1 (fr) * | 1993-01-15 | 1995-03-17 | Synthelabo | Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique. |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CN103601792B (zh) | 2007-06-04 | 2016-06-29 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US8592431B2 (en) * | 2009-01-30 | 2013-11-26 | Takeda Pharmaceutical Company Limited | Fused ring compound and use thereof |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
US5064825A (en) * | 1989-06-01 | 1991-11-12 | Merck & Co., Inc. | Angiotensin ii antagonists |
DE69025473T2 (de) * | 1989-06-30 | 1996-10-17 | Du Pont | Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii |
EP0407342A3 (en) * | 1989-07-06 | 1991-07-10 | Ciba-Geigy Ag | Pyrimidine derivatives |
EP0424317A3 (en) * | 1989-10-19 | 1991-09-25 | Ciba-Geigy Ag | Pyrimidines |
EP0435827A3 (en) * | 1989-12-28 | 1991-11-13 | Ciba-Geigy Ag | Diaza compounds |
EP0522038A4 (en) * | 1990-03-30 | 1993-05-26 | Merck & Co. Inc. | Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
IE912114A1 (en) * | 1990-07-02 | 1992-01-15 | Union Pharma Scient Appl | Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present |
-
1991
- 1991-02-20 FR FR9102032A patent/FR2672892B1/fr not_active Expired - Fee Related
-
1992
- 1992-02-03 AT AT92400269T patent/ATE135695T1/de not_active IP Right Cessation
- 1992-02-03 DK DK92400269.4T patent/DK0500409T3/da active
- 1992-02-03 DE DE69209113T patent/DE69209113T2/de not_active Expired - Fee Related
- 1992-02-03 ES ES92400269T patent/ES2086090T3/es not_active Expired - Lifetime
- 1992-02-03 EP EP92400269A patent/EP0500409B1/fr not_active Expired - Lifetime
- 1992-02-19 AU AU11059/92A patent/AU650319B2/en not_active Ceased
- 1992-02-19 CN CN92101114A patent/CN1034171C/zh not_active Expired - Fee Related
- 1992-02-19 NZ NZ241659A patent/NZ241659A/xx unknown
- 1992-02-19 JP JP4031862A patent/JP2529798B2/ja not_active Expired - Lifetime
- 1992-02-19 MX MX9200690A patent/MX9200690A/es not_active IP Right Cessation
- 1992-02-19 HU HU9200532A patent/HUT60477A/hu unknown
- 1992-02-19 RU SU925010817A patent/RU2073675C1/ru active
- 1992-02-19 IL IL10101492A patent/IL101014A/en not_active IP Right Cessation
- 1992-02-19 KR KR1019920002504A patent/KR920016434A/ko not_active Application Discontinuation
- 1992-02-19 FI FI920720A patent/FI920720A/fi unknown
- 1992-02-19 IE IE920525A patent/IE76145B1/en not_active IP Right Cessation
- 1992-02-19 ZA ZA921203A patent/ZA921203B/xx unknown
- 1992-02-19 CS CS92490A patent/CS49092A3/cs unknown
- 1992-02-19 CA CA002061456A patent/CA2061456A1/en not_active Abandoned
- 1992-02-19 PL PL92293531A patent/PL168617B1/pl unknown
- 1992-02-19 NO NO92920648A patent/NO920648L/no unknown
-
1995
- 1995-06-29 HU HU95P/P00554P patent/HU211886A9/hu unknown
-
1996
- 1996-03-21 GR GR960400758T patent/GR3019404T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL168617B1 (pl) | 1996-03-29 |
ES2086090T3 (es) | 1996-06-16 |
JPH04346980A (ja) | 1992-12-02 |
CN1064269A (zh) | 1992-09-09 |
IE920525A1 (en) | 1992-08-26 |
DK0500409T3 (da) | 1996-07-15 |
FR2672892A1 (fr) | 1992-08-21 |
HU211886A9 (en) | 1995-12-28 |
IE76145B1 (en) | 1997-10-08 |
PL293531A1 (en) | 1992-08-24 |
CA2061456A1 (en) | 1992-08-21 |
CS49092A3 (en) | 1992-09-16 |
EP0500409A1 (fr) | 1992-08-26 |
KR920016434A (ko) | 1992-09-24 |
RU2073675C1 (ru) | 1997-02-20 |
FR2672892B1 (fr) | 1994-01-14 |
HU9200532D0 (en) | 1992-05-28 |
ATE135695T1 (de) | 1996-04-15 |
MX9200690A (es) | 1992-08-01 |
FI920720A (fi) | 1992-08-21 |
JP2529798B2 (ja) | 1996-09-04 |
EP0500409B1 (fr) | 1996-03-20 |
DE69209113T2 (de) | 1996-10-31 |
HUT60477A (en) | 1992-09-28 |
NZ241659A (en) | 1993-03-26 |
DE69209113D1 (de) | 1996-04-25 |
AU650319B2 (en) | 1994-06-16 |
FI920720A0 (fi) | 1992-02-19 |
IL101014A (en) | 1996-06-18 |
CN1034171C (zh) | 1997-03-05 |
ZA921203B (en) | 1992-11-25 |
AU1105992A (en) | 1992-08-27 |
GR3019404T3 (en) | 1996-06-30 |
NO920648D0 (no) | 1992-02-19 |
IL101014A0 (en) | 1992-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO920648L (no) | 4-pyrimidonderivater, deres fremstilling og anvendelse | |
FI924869A (fi) | Kinolinderivat, foerfarande foer framstaellning av dessa och terapeutisk anvaendning av dessa | |
DE69202166D1 (de) | Verwendung von Tetrahydrothienopyridinderivate als Angiogenese-Inhibitoren. | |
FI941068A (fi) | Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
ES2064057T3 (es) | Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica. | |
ATE133951T1 (de) | Fluorierte bis(hydroxymethyl)cyclobutylpurine und -pyrimidine | |
AR046673A1 (es) | Derivados de difenilamina | |
DE69301639D1 (de) | Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung | |
NO922523L (no) | Aminopyrimidinkarboksamiddrivater med terapeutisk virkning | |
FI942265A0 (fi) | 2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö |